| Filed On | Filing |
|---|---|
| 29 Nov 2021 | 15-12B |
| 19 Nov 2021 | EFFECT |
| 19 Nov 2021 | EFFECT |
| 19 Nov 2021 |
Form 4: Walker Paul Edward, Director
Returned 5,736,363 shares to the issuer · Disposed of 850,000 Warrant to Purchase Common Shares (Disposition to Issuer) · Disposed of 6,750,000 Series II Non-Voting Convertible First Preferred Shares (Disposition to Issuer) · 2 more |
| 19 Nov 2021 |
Form 4: Pucci Paolo, Director
Disposed of 67,000 Stock Option (Right to Buy) (Disposition to Issuer) |
| 19 Nov 2021 |
Form 4: Myers Scott Dunseth, Director
Disposed of 67,000 Stock Option (Right to Buy) (Disposition to Issuer) |
| 19 Nov 2021 |
Form 4: Harrison Rosemary, See Remarks
Returned 75 shares to the issuer · Disposed of 180,000 Stock Option (Right to Buy) (Disposition to Issuer) |
| 19 Nov 2021 |
Form 4: Beshar Luke M, Director
Disposed of 46,666 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 547,656.26 Deferred Share Unit (Disposition to Issuer) |
| 19 Nov 2021 |
Form 4: Parsons James T., Chief Financial Officer
Disposed of 461,385 Stock Option (Right to Buy) (Disposition to Issuer) |
| 19 Nov 2021 |
Form 4: Kamarck Michael E., Director
Disposed of 67,000 Stock Option (Right to Buy) (Disposition to Issuer) |
| 19 Nov 2021 |
Form 4: Looker Benjamin, General Counsel
Disposed of 190,000 Stock Option (Right to Buy) (Disposition to Issuer) |
| 19 Nov 2021 |
Form 4: Mackey Catherine J, Director
Disposed of 67,000 Stock Option (Right to Buy) (Disposition to Issuer) |
| 19 Nov 2021 |
Form 4: Bruns Ingmar, Chief Medical Officer
Disposed of 400,000 Stock Option (Right to Buy) (Disposition to Issuer) |
| 19 Nov 2021 |
Form 4: Petrova Penka, Chief Development Officer
Disposed of 316,822 Stock Option (Right to Buy) (Disposition to Issuer) |
| 19 Nov 2021 |
Form 4: Uger Robert, Chief Scientific Officer
Disposed of 468,222 Stock Option (Right to Buy) (Disposition to Issuer) |
| 19 Nov 2021 |
Form 4: Tayton-martin Helen Katrina, Director
Disposed of 40,000 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 498,294.287 Deferred Share Unit (Disposition to Issuer) |
| 19 Nov 2021 |
Form 4: Skvarka Jan, Director
Disposed of 1,959,500 Stock Option (Right to Buy) (Disposition to Issuer) |
| 19 Nov 2021 | GROWTH EQUITY OPPORTUNITIES FUND V, LLC - TRILLIUM THERAPEUTICS -- SCHEDULE 13D/ |
| 17 Nov 2021 | S-8 POS |
| 17 Nov 2021 | POSASR |
Loading...
